An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project
- 1 November 2018
- journal article
- research article
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 3 (11) , 778-789
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4Journal of Hepatology, 2015
- Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virusHepatology, 2015
- Estimation of hepatitis C virus infections resulting from vertical transmission in EgyptHepatology, 2014
- The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesisBMC Infectious Diseases, 2013
- Case control study to identify risk factors for acute hepatitis C virus infection in EgyptBMC Infectious Diseases, 2012
- Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian womenTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Changing pattern of hepatitis C virus spread in rural areas of EgyptJournal of Hepatology, 2005
- Hepatitis C Virus Infection in A Community in the Nile Delta: Risk Factors for SeropositivityHepatology, 2001
- Hepatitis C virus (HCV) infection in a community in the nile delta: Population description and HCV prevalenceHepatology, 2000
- The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in EgyptThe Lancet, 2000